產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-DOCK4抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-DOCK4抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-DOCK4
Cat. Number:
Anti-DOCK4抗體KL-12432R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
DOCK 4 is a cytoplasmic peripheral membrane protein that belongs to the DOCK family of cytokinesis-regulating proteins. Expressed ubiquitously with highest expression in prostate, ovary and skeletal muscle, DOCK 4 functions as a guanine nucleotide exchange factor (GEF) that activates the small Anti-DOCK4抗體GTPase Rap 1 and, via this activation, plays a role in the regulation of adherens junctions between cells. Similar to other DOCK family members, DOCK 4 contains an N-terminal SH3 domain, a C-terminal proline-rich region and two internal DOCK homology regions designated DHR1 and DHR2. Defects in the gene encoding DOCK 4 result in the inactivation of Rap 1 and are, thus, implicated in the pathogenesis of various cancers such as ovarian, prostate, glioma and colorectal carcinomas. Four isoforms of DOCK 4 are expressed due to alternative splicing events.
Also known as:
Dedicator of cytokinesis protein 4;Anti-DOCK4抗體 Dock4; DOCK4_HUMAN; KIAA0716.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human DOCK4.
●
Predicted Molecular Weight: Anti-DOCK4抗體225kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must Anti-DOCK4抗體be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must Anti-DOCK4抗體be determined by the end user.
kl818Ra01 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
kl819Mu01 再生胰島衍生蛋白4(REG4)多克隆抗體 Polyclonal Antibody to Regenerating Islet Derived Protein 4 (REG4)
kl822Hu01 角蛋白17(KRT17)多克隆抗體 Polyclonal Antibody to Keratin 17 (KRT17)
kl823Hu01 補(bǔ)體成分9(C9)多克隆抗體 Polyclonal Antibody to Complement Component 9 (C9)
kl823Ra01 補(bǔ)體成分9(C9)多克隆抗體 Polyclonal Antibody to Complement Component 9 (C9)
kl824Ga01 核因子κB(NFκB)多克隆抗體 Polyclonal Antibody to Nuclear Factor Kappa B (NFkB)
kl824Hu01 核因子κB(NFκB)多克隆抗體 Polyclonal Antibody to Nuclear Factor Kappa B (NFkB)
kl824Mu01 核因子κB(NFκB)多克隆抗體 Polyclonal Antibody to Nuclear Factor Kappa B (NFkB)
kl824Ra01 核因子κB(NFκB)多克隆抗體 Polyclonal Antibody to Nuclear Factor Kappa B (NFkB)
kl825Mu01 核因子κB2(NFκB2)多克隆抗體 Polyclonal Antibody to Nuclear Factor Kappa B2 (NFkB2)
kl826Hu01 V-Rel網(wǎng)狀內(nèi)皮增生病毒癌基因同源物B(RELB)多克隆抗體 Polyclonal Antibody to V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB)
kl827Hu01 軸突生長(zhǎng)誘向因子1(Ntn1)多克隆抗體 Polyclonal Antibody to Netrin 1 (Ntn1)
kl827Mu01 軸突生長(zhǎng)誘向因子1(Ntn1)多克隆抗體 Polyclonal Antibody to Netrin 1 (Ntn1)
kl827Ra01 軸突生長(zhǎng)誘向因子1(Ntn1)多克隆抗體 Polyclonal Antibody to Netrin 1 (Ntn1)
kl828Hu01 載脂蛋白C4(APOC4)多克隆抗體 Polyclonal Antibody to Apolipoprotein C4 (APOC4)
kl828Mu01 載脂蛋白C4(APOC4)多克隆抗體 Polyclonal Antibody to Apolipoprotein C4 (APOC4)
